Active-ingredient Dossier
Bivalirudin
Active-ingredient Dossier for Bivalirudin (direct thrombin inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: BIVALIRUDIN
- Brand: Bivalirudin
- Brand: BIVALIRUDIN
- Brand: APO-Bivalirudin
- Therapeutic area: Cardiology
What is
Bivalirudin Bivalirudin is a direct thrombin inhibitor.
Australian brands containing
Bivalirudin — BIVALIRUDIN — Bivalirudin — APO-Bivalirudin
Therapeutic areas
Bivalirudin is registered in cardiology, with 5 brands containing the ingredient.
Sponsor landscape
The ingredient is marketed by four sponsors: Arrotex Pharmaceuticals, Southern XP IP, Medsurge Pharma, and Juno Pharmaceuticals.
PBS and regulatory activity
One brand containing bivalirudin has a PBS-listed item, with the latest PBS schedule date of 1 May 2026.